Published Date: 26 Apr 2023
In order to plan the size and placement of the implant as well as the entire procedure, the dentist inserting the implant must be aware of the precise location of the patient's lower jaw's nerve canal. X-ray images are required for this.
Read Full NewsIZAR-1: Sonelokimab Meets Phase 3 End Points for PsA
Two-season real-world data show Arexvy reduces RSV-related MACE and COPD and asthma exacerbations in adults 60 and older, Ann Falsey, MD, says.
Guy Brusselle, MD, PhD, says that 64% of dupilumab-treated patients met composite asthma clinical remission criteria at week 24 versus 40.5% with omalizumab.
What The FDA Psychedelic Hearing Means for Psychiatrists
A new phase 4 trial, OCTAGON, will test a rapid, predefined corticosteroid-tapering schedule in patients with generalized myasthenia gravis treated with ravulizumab.
A phase 4 study is evaluating whether adults with chronic inflammatory demyelinating polyneuropathy can transition from intravenous immunoglobulin to subcutaneous efgartigimod PH20 without first experiencing disease worsening.
Real-world 12‑month results from WeSMA, a phase 4 study, showed that oral risdiplam is well tolerated in adults with SMA, with stable motor function and consistent safety findings.
1.
November 2023, Medical Bulletin 04/.
2.
Remote CBT for Insomnia Improves Symptoms During Chemo
3.
Vaccine shows promise for pancreatic cancer, study finds
4.
Powerlifting through breast cancer: How a breast cancer survivor defied chemotherapy with strength training
5.
Some low-grade prostate cancers carry higher risks than biopsy suggests
1.
Understanding Drug-Induced Cardiotoxicity: Mechanisms, Impact, and Future Directions
2.
Refining AML Survival: Prognostic Factors, Therapies, and Stem Cell Strategies Reviewed
3.
Exploring the Pleomorphic Adenoma: A Unique and Varied Tumor
4.
Beyond Immunotherapy: Emerging Novel Treatments for Small Cell Lung Cancer
5.
The importance of understanding normal serum osmolality
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
1.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII
3.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII
5.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation